Cantor Fitzgerald Reiterates Overweight on Prothena Corp, Maintains $129 Price Target
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Charles Duncan reiterated an Overweight rating on Prothena Corp (NASDAQ:PRTA) and maintained a $129 price target.
June 21, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Charles Duncan reiterated an Overweight rating on Prothena Corp and maintained a $129 price target.
The Overweight rating and maintained price target by Cantor Fitzgerald analyst Charles Duncan indicate a positive outlook for Prothena Corp's stock in the short term. This news is highly relevant and important for investors in PRTA, as it reflects the analyst's confidence in the company's performance and potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100